Genomics-driven innovation as a catalyst for growth

Stephane Mattatia, Global Head of Derivatives Licensing and Thematic Indexes at MSCI, Caique Cardoso, ETF Specialist at Itau, Simon Barnett, Director of Life Sciences Research at ARK Invest share their views on how genomics innovation is creating opportunities for investors. These innovations encompass technological and scientific developments in DNA sequencing, gene editing, targeted therapeutics, bioinformatics, and agricultural biology.